Precision Biosciences (DTIL) Revenue (2018 - 2026)
Precision Biosciences (DTIL) reported Revenue of $10.8 million for Q1 2026, up 37272.41% year-over-year from N/an in Q1 2025, and down 68.31% quarter-over-quarter from $34.2 million in Q4 2025.
Precision Biosciences (DTIL) Revenue (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Revenue data on file, last reported at $10.8 million in Q1 2026.
- Revenue for Q1 2026 came in at $10.8 million, up 37272.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.1 million (down 11.87% YoY), and the FY2025 annual result was $34.3 million, down 50.12% from the prior year.
- Revenue fell to $10.8 million in Q1 2026 per DTIL's latest filing, from $34.2 million in the prior quarter.
- Over five years, Revenue peaked at $49.9 million in Q2 2024 and troughed at $13000.0 in Q3 2025.
- A 5-year average of $11.0 million and a median of $7.4 million in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2025 and 2026: Revenue sank 99.96% in 2025, then jumped 37272.41% in 2026.
- A 5-year view of Revenue shows it stood at $10.6 million in 2022, then slumped by 33.59% to $7.0 million in 2023, then sank by 90.93% to $638000.0 in 2024, then soared by 5261.13% to $34.2 million in 2025, then tumbled by 68.31% to $10.8 million in 2026.
- Business Quant data shows DTIL's Revenue at $10.8 million in Q1 2026, $34.2 million in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Precision Biosciences | 150.27 Mn | 49.09 Mn | - | 10.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.84 Mn |
| Dec 31, 2025 | 34.20 Mn |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 49.90 Mn |
| Mar 31, 2024 | 17.58 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Sep 30, 2023 | 13.12 Mn |
| Jun 30, 2023 | 19.79 Mn |
| Mar 31, 2023 | 8.78 Mn |
| Dec 31, 2022 | 10.60 Mn |
| Sep 30, 2022 | 7.36 Mn |
| Jun 30, 2022 | 3.82 Mn |
| Mar 31, 2022 | 3.32 Mn |
| Dec 31, 2021 | 6.34 Mn |
| Sep 30, 2021 | 24.04 Mn |
| Jun 30, 2021 | 68.81 Mn |